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The adverse pulmonary effects of asbestos are well accepted in scientiﬁc circles. However, the
extrapulmonary consequences of asbestos exposure are not as clearly deﬁned. In this review
the potential for asbestos to produce diseases of the peritoneum, immune, gastrointestinal
(GIT), and reproductive systems are explored as evidenced in published, peer-reviewed lit-
erature. Several hundred epidemiological, in vivo, and in vitro publications analyzing the
extrapulmonary effects of asbestos were used as sources to arrive at the conclusions and
to establish areas needing further study. In order to be considered, each study had to
monitor extrapulmonary outcomes following exposure to asbestos. The literature supports
a strong association between asbestos exposure and peritoneal neoplasms. Correlations
between asbestos exposure and immune-related disease are less conclusive; nevertheless, it
was concluded from the combined autoimmune studies that there is a possibility for a high-
er-than-expected risk of systemic autoimmune disease among asbestos-exposed populations.
In general, the GIT effects of asbestos exposure appear to be minimal, with the most likely
outcome being development of stomach cancer. However, IARC recently concluded the evi-
dence to support asbestos-induced stomach cancer to be “limited.” The strongest evidence
for reproductive disease due to asbestos is in regard to ovarian cancer. Unfortunately, effects
on fertility and the developing fetus are under-studied. The possibility of other asbestos-in-
duced health effects does exist. These include brain-related tumors, blood disorders due
to the mutagenic and hemolytic properties of asbestos, and peritoneal ﬁbrosis. It is clear
from the literature that the adverse properties of asbestos are not conﬁned to the pulmonary
system.
For this review, several hundred epidemio-
logical, in vivo, and in vitro publications ana-
lyzing the extrapulmonary effects of asbestos
were used as sources to (1) arrive at the con-
clusions and (2) establish areas needing fur-
ther study. In order to be considered, each
study had to monitor extrapulmonary out-
comes following exposure to asbestos. Papers
were identiﬁed using keyword searches focus-
ing on the term “asbestos” and its subtypes.
Therefore, differences in author interpretations
of what qualiﬁes as asbestos may exist. Only
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primary epidemiological studies were used to
reach the conclusions; however, reports ana-
lyzing multiple cohort studies are discussed
when appropriate. For animal studies, inhala-
tion experiments were only included if nonpul-
monary outcomes are reported. Similarly, only
in vitro studies utilizing cells that were not iso-
lated from the pulmonary system are included.
When possible, the type of asbestos exposure
is incorporated into the discussion in order
to establish differences in the extrapulmonary
effects of chrysotile versus the amphiboles.
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Route of exposure is also an important
consideration in evaluating the extrapulmonary
effects of asbestos. Although traditionally
considered to be an inhaled toxicant, asbestos
exposure might also occur through ingestion of
contaminated food and water. Other potential
routes of exposure include transplacental trans-
fer and introduction to the reproductive system
during coitus. When feasible, differences in
route of exposure and resulting outcomes are
discussed.
In compiling the literature referenced in
this article, it was necessary to depend on the
authors’ interpretations and conclusions from
the data. Therefore, a signiﬁcant limitation of
this review is our reliance on the reported out-
comes from each study. However, each paper
was published as part of a peer-review pro-
cess and when the papers are as a whole
they should represent the best evidence avail-
able. In addition, there is a paucity of data
examining some of the extrapulmonary effects.
For example, although transplacental transfer of
asbestos appears to occur, there are an appre-
ciably limited number of publications address-
ing the issue. As a consequence, the scarcity
in the number of studies is also a limitation of
this report. In addition, there are broad dis-
crepancies in the conclusions drawn from the
various studies. These differences are discussed
when needed. Finally, the vast majority of
these studies focus on the effects of chrysotile
and/or crocidolite exposure. However, there
are reports of other amphiboles being associ-
ated with development of various cancer types.
The limited number of these studies makes it
difﬁcult to draw conclusions; however, their
potential to cause disease may be signiﬁcant.
PERITONEAL EFFECTS OF ASBESTOS
Mesothelioma, which most commonly
occurs in the pleural space of the lung fol-
lowed by the peritoneum, is primarily linked to
asbestos exposure (Boffetta, 2007). Peritoneal
mesothelioma (PM) is the most common neo-
plasm of the peritoneum (Mack, 1995) and
along with pleural mesothelioma was recently
attributed to an expected survival time of 7.6
and 13.5 mo for males and females following
diagnosis, respectively. With mesothelioma
described as an “aggressive neoplasm that
rapidly spreads within the conﬁnes of the
abdominal cavity to involve most accessible
peritoneal and omental surfaces,” treatment
regimes are largely unsuccessful (Hesdorffer
et al., 2008). Consequently, prevention remains
the best option for managing PM. Therefore,
an understanding of the temporal and dose-
response aspects associated with the develop-
ment of the disease remains a critical task of the
scientiﬁc community.
Epidemiological Evidence
It is widely accepted that asbestos expo-
sure results in an increased risk for peri-
toneal cancers in general and mesothelioma,
speciﬁcally (Armstrong et al., 1984; Boffetta,
2007; Welch et al., 2005; McDonald et al.,
2006; Sluis-Cremer et al., 1992; Browne and
Smither, 1983; Selikoff et al., 1984; Ribak
et al., 1988). There are a number of asbestos-
exposed cohorts with a documented link to
cancer, including PM. For example, studies
on an Australian cohort of crocidolite-exposed
workers from the Wittenoom factory reported
increased rates of peritoneal cancer (Berry
et al., 2004; de Klerk et al., 1989; Reid et al.,
2005; Musk et al., 1989), which remain con-
sistent in Italian workers who later resettled
in Italy (Merler et al., 2000). In addition,
Canadian factory workers exposed primarily to
chrysotile, with minor exposures to crocidolite,
demonstrated an increased incidence of PM
(McDonald, 1980). However, in the Canadian
study, the risk was found to be less severe in
workers only exposed to chrysotile as com-
pared to a mixed exposure. Furthermore, a
later study by McDonald et al. (1997), found
no cases of peritoneal mesothelioma in a large
cohort of Canadian workers exposed primarily
to chrysotile. Consequently, evidence suggests
that crocidolite is a more potent inducer of PM
than chrysotile alone. In addition to chrysotile
and crocidolite, amosite has been associated
with a signiﬁcant number of PM cases in a
cohort of exposed workers (Ribak et al., 1989).
It is becoming increasingly apparent that
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inﬂuence on the location and possibly severity
of any developing neoplasm. While chrysotile
ﬁbers were detected in peritoneal mesothe-
liomas from North American insulation
workers (Kohyama & Suzuki, 1991), in a
study of Norwegian asbestos-cement workers
primarily exposed to chrysotile, no peritoneal
mesotheliomas were reported (Ulvestad et al.,
2002). In addition, further analysis of Australian
mesothelioma cases reported that higher lung
ﬁber burdens (as measured by light microscopy
(LM) and analytic transmission electron
microscopy (TEM) with energy-dispersive
x-ray analysis (EDXA) are associated with a
greater risk for peritoneal tumors for all ﬁber
types except chrysotile (Leigh et al., 1991).
Therefore, it is highly likely that crocidolite
(and possibly other amphibole) exposure
poses the greatest threat for development of
peritoneal tumors, including mesothelioma. In
addition, ﬁber size appears to be an important
factor in the carcinogenicity of asbestos. In a
study using high-resolution analytical electron
microscopy to determine the dimensions of
asbestos ﬁbers in 168 cases of mesothelioma,
the majority of the ﬁbers were shorter than
5 μm in length (Suzuki & Yuen, 2002).
Type and Route of Exposure
The type of asbestos exposure (i.e.,
chrysotile versus crocidolite and other amphi-
boles) appears to play an important role in
the development of peritoneal neoplasms.
While there is some evidence linking chrysotile
asbestos with peritoneal tumors, it is evident
from the literature that occupational exposure
to crocidolite poses a far greater health threat.
In addition, studies using rodents as a model
for human disease found similar differences
between chrysotile and crocidolite in their
ability to induce peritoneal tumors. In mice,
intraperitoneal (ip) injections of native croci-
dolite produced a greater angiogenic response
around developing tumors than chrysotile
(Branchaud et al., 1989). Furthermore, devel-
opment of peritoneal tumors in rats increased
in a clear dose-dependent manner with
UICC standard reference samples of crocidolite
(Davis et al., 1991), and evidence suggests the
same occurs in humans (Browne & Smither,
1983; Leigh et al., 1991).
The precise pathway resulting in peritoneal
exposure to asbestos is not clear, as there
is no known mechanism for direct contact.
However, based on studies suggesting systemic
distribution of asbestos following inhalation
and ingestion, it is likely that direct contact
does occur. Furthermore, it is possible that
activation of signaling cascades initiated in
the lung affect disease in the peritoneum.
Speciﬁcally, transforming growth factor-beta
(TGF-β) was implicated in asbestos-induced
disease. A recent examination of an asbestosis
cohort revealed that serum levels of TGF-β
were found to correlate well with peritoneal
disease severity, increasing approximately
2.4-fold from ILO radiographic category 0 to
category 3 (Li et al., 2009).
Animal Studies
Rodents have commonly provided a reli-
able model for studying the peritoneal effects
of asbestos. Reports describing development of
peritoneal tumors in mice (Suzuki & Kohyama,
1984; Branchaud et al., 1989) and rats
(Adachi et al., 2001; Davis and Jones, 1988;
Unfried et al., 1997; Craighead et al., 1987;
Cullen et al., 2002; Minardi & Maltoni, 1988)
are relatively abundant. In addition, attempts at
elucidating mechanisms have uncovered clues
as to the development of asbestos-induced
peritoneal tumors. In general, administration
of crocidolite (ip) appears to result in ﬁber
aggregates in peritoneal macrophages, exudate
cells and ﬁbrous tissue—eventually develop-
ing into granulomas (Koerten et al., 1990). In
mice, crocidolite ﬁbers recovered via bleach
digestion and analyzed by stereomicroscopy,
scanning electron microscopy, and/or autora-
diography (Moalli et al., 1987; Macdonald &
Kane, 1997) from the peritoneal lining do not
decline in number as much as 6 mo following
ip administration. The biopersistent properties
of crocidolite resulted in chronic inﬂammation
and mesothelial cell proliferation. In addition,
crocidolite administered to rats ip resulted in
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cells (Lee et al., 1993). In these rats, the normal
microvillous surface of the mesothelium was
replaced with proliferating mesothelial cells
within 7 d of exposure.
In mice, crocidolite ip given in doses rang-
ing from 104 to 108 ﬁbers resulted in a dose-
dependent recruitment of inﬂammatory cells
to the peritoneal cavity (Cullen et al., 2000).
These stimulated macrophages show increased
concentrations of iron (Fe) in both the lyso-
some and cytoplasm, suggesting an increase
in oxidative potential (Koerten et al., 1986)
(for additional information see Aust et al., this
issue) Further, 100% of rats given a single
ip injection of de-ironized crocidolite plus Fe
supplements developed peritoneal mesothe-
liomas, whereas only 40% and 50% devel-
oped mesotheliomas when given de-ironized
crocidolite or unmodiﬁed crocidolite alone,
respectively (Adachi et al., 1994). It is evident,
therefore, that Fe plays a role in crocidolite’s
carcinogenic potential, likely due to an increase
in oxidative stress. In fact, the mutagenic poten-
tial of asbestos is thought to at least be partially
due to oxygen radicals, as its mutagenicity is
reduced by antioxidants in human whole blood
lymphocytes (Korkina et al., 1992) (for addi-
tional information see Hei et al., this issue).
Moreover, growth of chrysotile-induced lung
carcinomas transplanted into the peritoneal
cavity of mice is inhibited by treatment with
trans-retinoic acid by 58–64% (Hubert et al.,
1983).
It is likely that the carcinogenic effects
of asbestos are linked to mutations in cer-
tain genes in addition to chromosomal aber-
rations (CA). For example, ip administration of
chrysotile in mice results in an increase in the
level of damaged chromosomes in peritoneal
cells (Durnev et al., 1993). Moreover, chrysotile
induced CA in human lymphocytes, whole
blood cultures, peritoneal ﬂuid, and bone-
marrow cells in mice (Durnev et al., 1993).
In addition, heterozygous transgenic Nf2(−/+)
mice showed accelerated development of
peritoneal mesotheliomas following crocido-
lite exposure (Kane, 2006; Fleury-Feith et al.,
2003). Tumors from these mice also demon-
strated frequent homozygous deletions of the
Cdkn2a/Arf locus and adjacent Cdkn2b tumor
suppressor gene (Altomare et al., 2005) (for
additional information see Testa et al., this
issue). Finally, TP53(−/+) mice given a weekly
ip injection of UICC crocidolite showed an
increased incidence and decreased latency of
peritoneal mesothelioma development (Vaslet
et al., 2002).
In Vitro Studies
A signiﬁcant body of literature has accumu-
lated using peritoneal macrophages and other
cell lines to study the mechanisms of asbestos-
induced disease. It is known that applying
crocidolite or chrysotile to lavaged peritoneal
macrophages results in protrusion of ﬁbers from
membrane-bound vacuoles, as well as free in
the cytoplasm and penetrating the nucleus,
as seen by both scanning electron microscopy
(SEM) and TEM (Johnson and Davies, 1981).
The role of Fe in asbestos toxicity has also
been studied in vitro. The ability of mouse
peritoneal macrophages to take up UICC cro-
cidolite is dependent on ﬁber size and avail-
ability of Fe as measured by either LM or TEM
(Koerten et al., 1990). Speciﬁcally, small ﬁbers
were internalized and long ﬁbers were left to
form asbestos bodies in an Fe-dependent man-
ner. Furthermore, crocidolite-stimulated nitric
oxide synthase (NOS) activity and expression
in murine glial cells was inhibited by Fe sup-
plementation and enhanced by Fe chelation
(Aldieri et al., 2001). Due to the ability of Fe
to generate free radicals, in vitro tests were
conducted to determine whether oxidative
stress played a role in the toxicity of asbestos.
Indeed, when mouse peritoneal macrophages
were incubated with crocidolite, reactive oxy-
gen metabolites were released (Goodglick &
Kane, 1986). The free-radical-generating abil-
ity of chrysotile may be prevented in the
presence of antioxidants. Speciﬁcally, in rat
peritoneal macrophages, a decrease in phago-
cytosis, cell injury, and lactate dehydrogenase
(LDH) activity release was observed when
cells were exposed to ﬂavonoids along with
chrysotile (Kostyuk & Potapovich, 1998). The
ﬂavonoids quercetin, dihydroquercetin, and126 M. BUNDERSON-SCHELVAN ET AL.
rutin were effective in the same order as their
superoxide scavenging potential. In addition,
metal-complexed ﬂavonoids with improved
radical scavenging ability are more potent in
their protective effects against natural chrysotile
(Tuva, Russia) toxicity (Kostyuk et al., 2001).
Similarly, green tea extracts protected peri-
toneal macrophages and red blood cells from
chrysotile toxicity (Kostyuk et al., 2000).
Modulation of the immune functions fol-
lowing asbestos exposure has also been exam-
ined using cultured peritoneal macrophages.
Addition of chrysotile to these cells stimu-
lated the release of lymphocyte-activating fac-
tors (Godelaine & Beaufay, 1989) as well as
plasminogen activator, which was prevented
by the addition of low concentrations of
anti-inﬂammatory steroids (Hamilton, 1983).
Summary
The association between asbestos expo-
sure and peritoneal neoplasms, speciﬁcally
mesothelioma, has been well established (see
Table 1). It is becoming increasingly apparent
that crocidolite poses a greater risk for devel-
opment of disease than chrysotile, and this
risk is proportional to amount and duration of
exposure. However, this issue remains unre-
solved due to the extremely toxic properties of
chrysotile in vitro.
In summary the following were
concluded:
• Occupational exposure to crocidolite and
other amphiboles poses the greatest risk for
development of peritoneal tumors as com-
pared to chrysotile.
• Risk increases in a dose-dependent manner.
• Studies suggest that changes in iron over-
load resulting in increased oxidative stress is
an important mechanism attributable to the
development of asbestos-induced peritoneal
cancer.
• Fiber size may affect in vitro effects due to
differences in internalization, but more data
is needed.
The following are areas that need further
study:
• The role of an antioxidant-poor diet in the
development of asbestos-induced peritoneal
tumors.
• Genetic factors that may be important in
development of disease.
• Impact of mineral composition of ﬁbers.
• Translocation of asbestos ﬁbers to the
peritoneum and/or other possible sig-
naling mechanisms involved in disease
development.
TABLE 1. Publications on Asbestos-Induced Peritoneal Disease
Fiber type Human Human Animal
Endpoint (if known) (Occupational) (water/ingested) (inhalation) Animal (ip)
Peritoneal mesothelioma Chrysotile or mixed 2(–)a 4(+)b
Crocidolite 9(+)c 4(+)d
Unknown 2(+)e
1(–)f
Amosite 1(+)g
Peritoneal cancer (general) Chrysotile 1(+)h 1(+)i 1(–)j
Crocidolite 1(+)k
Peritoneal ﬁbrosis Chrysotile 1(+)l
Crocidolite and amosite 1(+)m
Note. The number indicates how many articles were found with a positive (+) or negative (–) association between asbestos and
disease. “Unknown” exposures indicate the data came from occupational exposure matrices, including textiles, insulation, or cement
workers. Sources: aUlvestad, 2002; Albin, 1990. bAdachi, 2001; Davis, 1988; Minardi, 1988; Suzuki, 1984. cArmstrong, 1984; de Klerk,
1989b; Reid, 2005; Browne, 1983; McDonald, 2006; Musk, 1989; Sluis-Cremer, 1992; McDonald, 1997; Merler, 2000. dMinardi, 1988;
Adachi, 1994; Branchaud, 1989; Cullen, 2002. eRibak, 1988; Selikoff, 1984. fLumley, 1976. gSuzuki, 1984. hPira, 2009. iKanarek, 1980.
jBoorman, 1984. kKoerten, 1990b. lBateman, 1982. mWirth, 1975.NONPULMONARY OUTCOMES OF ASBESTOS EXPOSURE 127
AUTOIMMUNE EFFECTS OF ASBESTOS
Although it has become fairly well accepted
that speciﬁc systemic autoimmune diseases
(SAID) such as systemic lupus erythematosus
(SLE), systemic sclerosis (SSc), and rheuma-
toid arthritis (RA) are associated with silica
exposure, asbestos exposure has not yet been
strongly linked with any particular autoimmune
or connective tissue disorder. There are several
possibilities for this knowledge gap, including
a lack of statistical power due to relatively
small or diffuse exposure cohorts, exposure
assessment problems, the latency of the clinical
disease, and mild clinical or subclinical enti-
ties that remain undetected or masked by other
pathologies. It is also possible that asbestos
exposure poses a very low risk of autoimmune
pathology despite the presence of the charac-
teristic autoantibodies. Nevertheless, the data
are convincing in that there are immune abnor-
malities and humoral indices consistent with
autoimmune mechanisms, including a variety
of autoantibodies such as antinuclear antibod-
ies (ANA), rheumatoid factor (RF), and a gen-
eral increase in serum immunoglobulin (Ig) of
the IgG and IgA classes.
Epidemiological Evidence
Asbestos exposure and autoantibodies
There are fewer than 100 epidemiological
studies that have explored an association
between asbestos exposure and SAID (see
Table 2). However, studies of the humoral
responses following asbestos exposure appear
in the literature beginning around 1965 when
the presence of RF and ANA was reported in
asbestos workers (Pernis et al., 1965). Several
subsequent studies also found increased fre-
quency of positive RF tests in asbestos workers
compared to controls (Turner-Warwick &
Parkes, 1970; Stansﬁeld & Edge, 1974; Lange
TABLE 2. Publications on Asbestos-Induced Autoimmune Disease
Primary exposure Type of Human Animal Case
Endpoint (if known) exposure studies studies study
Rheumatoid athritis Unknown Occupational (e.g.,
cement worker)
1(+)a,1 ( – ) b 1(+)c
Amphibole (Libby) Occup/environ 1(+)d
SLE or lupus-like Tremolite Pulmonary instillation 1(++)e
Amphibole Occup/environ 1(+)d,1 ( – ) b
Scleroderma Chrysotile, amphibole Occupational 2(+)f
Autoimmune vasculitis Unknown Occupational 2(+)g,1 ( – ) h
Interstitial pneumonia
(ANCA-associated)
Unknown Occupational 1(+)i 1(+)j
Autoantibodies ANA chrysotile Occupational 1(+)k
Tremolite Occupational,
intratracheal
1(++)l 1(++)e
Various Occupational 4(+)m
Autoantibodies ANCA Unknown Occupational 1(+)n
Amphibole Occup/environ 1(–)o
Autoantibodies IgM Rh
factor
Chrysotile Occupational 4(+)p
Unknown Occupational 2(–)q
Amphibole Occup/environ 1(–)o
Rheumatoid, nonspeciﬁc chrysotile Occupational 1(+)r
Periaortitis or
retroperitoneal ﬁbrosis
Mixed (chrysotile and
amphiboles)
Occupational 5(+)s 1(+)t
Note. The number indicates how many articles were found with a positive (+) or negative (–) association between asbestos and disease.
“Unknown” or “various” exposures indicate the data came from occupational exposure matrices, including textiles, insulation, or cement
workers. Sources: aOlsson, 2004. bGold, 2007. cGreaves, 1979. dNoonan, 2006. ePfau, 2008. fGold, 2007; Noonan, 2006. gRihova,
2005; Inoue, 2004. hStratta, 2001. iRihova, 2005. jInoue, 2004. kTurner-Warwick, 1970. lZerva, 1989. mPfau, 2005; Nigam, 1993;
Tamura, 1993; Stansﬁeld, 1974. nPelclova, 2003. oPfau, 2005. pPernis, 1965; Turner-Warwick, 1970; Stansﬁeld, 1974; Lange, 1974.
qZone, 1985; Zerva, 1989. rWhite, 1974. svan Bommel, 2009; Vaglio, 2009; Uibu, 2004; Sauni, 1998; Maguire, 1991. tCottin, 2008.128 M. BUNDERSON-SCHELVAN ET AL.
et al., 1974), but others demonstrated no asso-
ciation (Zone & Rom, 1985; Zerva et al., 1989;
Pfau et al., 2005). There are undoubtedly dif-
ferences in serum dilutions and technical
approaches that may explain these differences.
A more speciﬁc early detection marker for
RA, antibodies to cyclic citrullinated proteins
(anti-CCP), may help clarify this. However, the
only known study of these autoantibodies in
an asbestos-exposed population showed no
increase in anti-CCP compared to controls
(Pfau et al., 2008).
Some of these same studies did show an
increase in ANA frequency with asbestos expo-
sure, and despite technical disparities, small
study sizes, and limited exposure assessments,
the combined strength of these studies is
compelling (Turner-Warwick & Parkes, 1970;
Stansﬁeld & Edge, 1974; Zerva et al., 1989;
Pfau et al., 2005; Tamura et al. 1993; Nigam
et al. 1993). Only one study indicated no
association of positive ANA tests with asbestos
exposure, but that study only consisted of
25 asbestos workers (Zone & Rom, 1985),
and other immunological indices were pos-
itive, such as increased serum IgG/IgA and
immune complexes. An interesting component
of some of these studies is the evaluation of
lung disease in ANA-positive patients, hypoth-
esizing that the antibodies might play a role
in ﬁbrosis. In all these cases, positive ANA
was associated with either more severe or
more rapid progression of lung disease (Pfau
et al., 2005; Gregor et al., 1979; Tamura
et al., 1996; Turner-Warwick, 1973). Further
study is needed, especially looking at differ-
ent forms of asbestos. One study found an
association of ANA seroconversion with only
interstitial ﬁbrosis, and another found an associ-
ation only with pleural plaques (Tamura et al.,
1996; Zerva et al., 1989). The former was a
study of chrysotile exposure, and the latter was
tremolite.
Only a couple of studies have attempted to
identify speciﬁc targets for the ANA, and a com-
monality is the presence of anti-dsDNA (Pfau
et al., 2005; Marczynski et al., 1994). Pfau et al.
(2009) hypothesized that further study of the
speciﬁcity of the autoantibodies might prove
extremely informative in terms of mechanism
of action, as well as diagnosis and progres-
sion. Antibodies to neutrophils (ANCA) were
associated with silica and asbestos exposure,
respectively (Pelclova et al., 2003). However,
Pfau et al. (2005) did not ﬁnd an association in
their asbestos-exposed cohort.
Systemic autoimmune disease Similar to
serological measurements, epidemiological
reports of asbestos-exposed cohorts tended to
be fairly small and suffer from problems with
exposure assessment. However, the combined
impact of these studies builds a fairly strong
caseforsystemicautoimmune/rheumatological
pathologies associated with asbestos exposure
of various ﬁber types. Most frequently reported
are associations with rheumatoid arthritis
(Olsson et al., 2004; Greaves, 1979; White
et al., 1974; Noonan et al., 2006). Other SAID
are so rare that a study population would have
to include nearly 100,000 subjects in order to
have statistical strength. A recent examination
of self-reported lupus or scleroderma patients
showed associations with asbestos exposure
based on extrapolations from a relatively small
population(Noonanetal.,2006).Nevertheless,
this account found a marked increase in the
frequency of these two diseases above what
would be expected in a population of that
size (less than 10,000), illustrating the need
for further assessment. A death certiﬁcate
study described an increased risk for SSc
deaths among persons having occupations
with likely exposure to asbestos (Gold et al.,
2007). Asbestos exposure was characterized
using a job exposure matrix developed by
an industrial hygienist. Interestingly, Gold
et al (2007) reported no increased risk for
RA or SLE mortality associated with asbestos
exposure, but it is possible that these two
diseases are not often given as cause of death
and therefore are not in the mortality statistics.
There has also been some evidence of an
association with ANCA-associated vasculitis
(Stratta et al., 2001; Rihova et al., 2005; Inoue
et al., 2004). This link may be underreported,
since a primary symptom of this disease is
interstitial pneumonias, which can be mistaken
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One of the strongest associations, based on
literature review, is between asbestos exposure
and periaortitis and retroperitoneal ﬁbrosis,
both of which are considered autoimmune dis-
eases (van Bommel et al., 2009; Vaglio, 2009;
Uibu et al., 2004; Sauni et al., 1998; Maguire
et al., 1991; Boulard et al., 1995). This pathol-
ogy is of interest due to the ﬁber burden of tis-
sues in this area of the body following asbestos
exposure (Uibu et al., 2009). Finally, it may
be important to note that among rescue and
recovery workers following the World Trade
Center disaster, a higher than expected inci-
dence of sarcoid-like disease has been reported
(Izbicki et al., 2007). These personnel may have
been exposed to asbestos during the rescue
and recovery effort, but asbestos was identiﬁed
as only one among hundreds of toxicants in the
World Trade Center dust. In addition, although
sarcoidosis is a multisystem disease that is
mediated through inﬂammatory mechanisms
that might place it under a broad deﬁnition
of SAIDs, there is not general agreement that
sarcoidosis should be considered an autoim-
mune disease. As the persons exposed to World
Trade Center dust continue to be followed over
time, the exact nature of ensuing pathologies
may become clearer, but it will be difﬁcult to
associate such outcomes with speciﬁc exposure
to asbestos in view of the complex mixture of
dusts.
Animal Studies
Animal studies of asbestos and autoimmu-
nity are extremely limited. A murine model of
asbestos-induced autoimmunity was recently
established by Pfau et al. (2008). Asbestos-
exposed C57Bl/6 mice developed positive
ANA tests and mild glomerulonephritis sug-
gestive of an SLE-like disease. These common
laboratory mice are not generally considered
autoimmune prone, so this pathology occurred
in the absence of a clear genetic predisposition
for a particular disease process. Interestingly,
the murine SLE-like disease was characterized
by the production of autoantibodies that rec-
ognize dsDNA and Ro52, reminiscent of what
was seen in the Libby asbestos exposures (Pfau
et al., 2005). Therefore, the murine model of
asbestos-induced autoimmunity appears to be
both relevant and useful to study the immuno-
logical effects of amphibole asbestos. Such
studies are critical to discovery of mechanism
of action. For example, the possibility that
autoantigens become antigenic due to prote-
olytic degradation or apoptotic processes was
postulated. During cell stress or death, Ro52
undergoes intracellular translocation and was
found to accumulate in apoptotic blebs during
programmed cell death induced by a variety
of oxidant challenges including asbestos. One
study in fact showed that autoantibodies from
asbestos-exposed mice bind to apoptotic blebs
in which Ro52 is accumulated (Blake et al.,
2008). In contrast to actual laboratory animal
studies of autoimmunity, more investigations
were conducted in animals to explore the
general immune effects of asbestos, described
below.
In Vitro/Ex Vivo Immune Cell Studies
Many early studies showed decreased
cell-mediated immunity in vitro and in vivo
following asbestos exposure, supporting the
hypothesis that asbestos is not only carcino-
genic, but also immunotoxic such that there is
inadequate immunity against the tumors that
arise. A few key papers are representative of
a huge literature base (Kagan et al., 1977;
Kagan, 1981; Lew et al., 1986; Manning et al.,
1991; Miura et al., 2008). However, this is
not really related to systemic autoimmunity,
since the SAID are for the most part humoral.
In fact, reduction of cell-mediated immunity
may indirectly enhance humoral immunity,
depending on the cellular/molecular mecha-
nism. However, among these studies are at least
two that provide evidence that silica produces
cellular events that are more likely to produce
autoimmune effects, whereas asbestos leads to
effects that may promote cancer by reducing
anti-tumor immunity (Nishimura et al., 2006;
Wu et al., 2005; Ueki et al., 1994). This may
help explain the stronger association of autoim-
mune disease with silica than asbestos, and
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For what would be considered nonpul-
monary disease such as SAID, however, there
are studies that explore what might be called
the “adjuvant” effect of asbestos. There are
excellent reviews exploring the immunological
effects of asbestos and attempting to link the
various pathologies via a uniﬁed immune dys-
regulation (Rom et al., 1991; Jagirdar et al.,
1997). Recent studies describe activation of
“inﬂammasomes” by asbestos and driving pro-
inﬂammatory effects such as IL-1β secretion
(Dostert et al., 2008). The inﬂammasome
approach may help explain the extremely
diverse effects of asbestos in surface markers
and cytokines that were reported over the years
(Miura et al., 2008; Wu et al., 2005; Ilavska
et al., 2005; Perkins et al., 1993; Holian et al.,
1997; Otsuki et al., 2007; Hannant et al.,1985;
Kinugawa et al., 1992; Thomas et al., 1994).
One of the recurring ideas in both silica and
asbestos immunotoxicology is that there are
two events that occur to perpetuate autoim-
mune responses. The ﬁrst is apoptosis, partic-
ularly of phagocytic cells such as the alveolar
macrophage, leading to accumulating cellu-
lar debris. The second is immune activation
via the “adjuvant” or inﬂammasome-activating
effects, which would drive antigen presentation
in an environment that is no longer tolerant of
the insult. Despite the appeal of this theory,
the literature thus far supports association, but
not necessarily causation (Holian et al., 1997;
Blake et al., 2008).
Summary
The limited number and scope of epi-
demiological studies that have explored a
causal association between asbestos exposure
and autoimmune disease make it difﬁcult to
draw conclusions (see Table 2). First, as with
most studies of asbestos, the observations just
described are focused primarily on male, occu-
pationally exposed populations. This could be
a limitation when evaluating clinical outcomes
such as autoimmune disease that are more
prevalent among women. The Libby study is
unique in that it includes a substantial number
of women with autoimmune disease who were
environmentally exposed to asbestos (Noonan
et al., 2006). Second, these studies are retro-
spective ones, which have limitations not only
in terms of exposure assessment but also in
terms of clarifying the temporal relationship
between exposure, autoimmune response, and
pulmonary manifestations of disease. Few of
these studies used an appropriate age-matched
comparison group. The quality of exposure
assessment varied among these studies, with
likely differences in the asbestos exposure clas-
siﬁcation. Serological analyses changed consid-
erably over time, with earlier studies relying on
tissue substrates for the studies while the cur-
rent standard used in the more recent studies is
HEp2 indirect immunoﬂuorescence assay.
Nevertheless, from the combined studies
the following were concluded:
• The frequency of positive ANA among
asbestos-exposed individuals is higher than
what would be observed among the general
population.
• There appears to be a higher-than-expected
risk of systemic autoimmune disease among
asbestos-exposed populations.
The following are speciﬁc areas that need
further study:
• Deﬁnition of an asbestos-associated autoim-
mune clinical entity (human mostly, but also
animal for modeling and mechanisms of
action).
• Temporal association between exposure and
autoantibodies, and between autoantibodies
and pulmonary disease (animal and human).
• Comparison of cellular/immune effects of
different ﬁber sizes and types (animal and in
vitro, human if possible).
• Speciﬁc autoantibody targets (animal and
human).
GASTROINTESTINAL EFFECTS
OF ASBESTOS
Asbestos-induced gastrointestinal tract
(GIT) cancer would appear to have aNONPULMONARY OUTCOMES OF ASBESTOS EXPOSURE 131
complicated etiology—dependent on the
route, type, and duration of exposure.
Environmental exposure through drinking
water from cement pipelines containing
chrysotile asbestos is the most obvious source
for GIT exposure. However, inadvertent “swal-
lowing” during occupational exposures and
systemic deliverance following inhalation are
also potential sources.
Epidemiological Evidence
Stomach cancer is the most consistently
reported outcome of GIT-related pathologies
due to asbestos exposure (Kjaerheim et al.,
2005; Kanarek et al., 1980; Polissar et al.,
1983; Andersen et al., 1993; Hillerdal, 1980).
However, there are reports of increased colon
(Kjaerheim et al., 2005; Germani et al., 1999)
and esophageal cancer (Kang et al., 1997)
in response to asbestos. In contrast, addi-
tional studies evaluating environmental expo-
sure to asbestos via the drinking water noted
no increased disease of the GIT on the whole,
including stomach cancer (Harrington et al.,
1978; Levy et al., 1976; Browne et al., 2005;
Hodgson & Jones, 1986; Toft & Meek, 1983).
It is possible that discrepancies in the conclu-
sion of these studies might be due to differ-
ences in the integrity of the asbestos pipelines
and therefore degree of exposure. In addi-
tion, mineral composition of the water likely
affects toxicity of the asbestos. Studies exam-
ining differences in the toxic properties of
asbestos found that it may be modulated by
changing the asbestos surface chemistry, specif-
ically Fe oxidation potential (Ghio et al., 1994).
Furthermore, presoaking asbestos ﬁbers with
the Fe chelator deferoxamine diminishes toxic-
ity in vitro (Weitzman et al., 1988; Goodglick &
Kane, 1986, 1990; Goodglick et al., 1989),
and modifying the surface of asbestos with
metal oxides reduces the hemolytic potential
of chrysotile, amosite, and crocidolite in sheep
erythrocytes (Hahon et al., 1986).
The effects of occupational asbestos expo-
sure on GIT cancers have also been exam-
ined in a number of studies. Occupational
exposures are generally higher than would
be expected from an environmental exposure
and include both inhalation and inadvertent
ingestion of asbestos ﬁbers. The evidence link-
ing occupational exposure to stomach cancer
is more convincing than studies examining
exposure through the drinking water and
appears to be primarily due to chrysotile or
crocidolite asbestos (Lumley, 1976; Raffn et al.,
1989; Newhouse et al., 1988; Armstrong et al.,
1988; Botha et al.,1986; Szeszenia-Dabrowska
et al., 1998; Sun et al., 2008; Enterline et al.,
1987). Again, studies focusing on the GIT as
a whole report little evidence to suggest a
relationship even when the exposure is occu-
pational in nature (Berry & Newhouse, 1983;
Churg & Warnock, 1979; Reid et al., 2004;
Thomas et al., 1982; de Klerk et al., 1989; Pira
et al., 2009; Albin et al., 1990; Gardner et al.,
1986; Finkelstein, 1989; Hodgson & Jones,
1986; Tsai et al., 1996). In fact, studies ﬁnding
a link between occupational asbestos and gen-
eral GIT cancers are few compared to studies
looking at speciﬁc endpoints, such as stom-
ach cancer (Weiss, 1977; Lacquet et al., 1980;
Finkelstein, 1984). Finally, a literature search
for a relationship between asbestos and inﬂam-
matory bowel diseases resulted in only one
suggestive report. In this case study, a pipeﬁtter
with known asbestos exposure and Crohn’s dis-
ease later developed cancer of the small bowel
(Lashner, 1992). However, given the inﬂam-
matory nature of asbestos-related pulmonary
diseases, the issue warrants consideration.
Type and Route of Exposure
Differences in the carcinogenic potential of
different asbestos ﬁbers are not as yet clear
as it relates to GIT disorders. There does,
however, appear to be more evidence linking
the chrysotile form to diseases of the GIT as
opposed to crocidolite.
The most likely route of exposure for GIT
disorders due to asbestos is in contaminated
drinking water. Millette et al. (1983) esti-
mated that the majority of water consumers
are exposed to less than 1 million ﬁbers/L, but
some populations could be exposed to greater
than 10 million ﬁbers/L. In fact, the California
aqueduct system has been reported to contain
billions of ﬁbers per liter as measured by three132 M. BUNDERSON-SCHELVAN ET AL.
separate ﬁltration processes followed by TEM
(McGuire et al., 1982). In addition, water sam-
ples analyzed via electron microscopy (EM)
revealed that the distribution of ﬁber size in
the water is dependent on its source. Asbestos
cement pipelines result in mean ﬁber lengths
of 4 μm and asbestos due to natural ero-
sion results in an average of 1-μm ﬁber pieces
(Millette et al., 1980). Furthermore, contami-
nated food supplies must also be considered
as a possible source (Rowe, 1983). It is impor-
tant to note that early methods for detection of
asbestos ﬁbers (including EM protocols) lacked
the ability to determine a statistically relevant
number of the long ﬁbers having the greatest
hazard potential (Lippmann, 1994).
An important consideration regarding GIT
exposure is transport and retention of ﬁbers,
since the GIT has large volume transport and
export that could eliminate the ﬁbers fairly
rapidly. No studies were found examining the
export of asbestos from the GIT
Animal Studies
Early attempts to discern mechanisms
underlying the carcinogenic potential of
asbestos ﬁbers show that ingestion of UICC
standard chrysotile A (5 mg/kg for 2 wk)
resulted in an increase in DNA synthesis
in the small intestine and colon of the rat
(Amacher et al., 1974). In addition, a rise in
the incorporation of [3H]thymidine into DNA
following ingestion of 50 mg/day for 1 wk
was observed (Jacobs et al., 1978). Glandular
stomach cancer was induced in rats by intra-
abdominal insertion of a pouch containing 100
mg chrysotile and beef fat (Kogan et al., 1987).
Furthermore, both crocidolite- and chrysotile-
gavaged rats (3 treatments of 33 mg/kg each)
showed induction of aberrant crypt foci,
which is indicative of colon carcinogenesis
(Corpet et al., 1993). Additional studies noted
cellular debris and Alcian blue staining in the
ileum, rectum, and colon along with mucosal
changes in the ileum 14 mo after ingestion of
50 mg/day chrysotile asbestos (Jacobs et al.,
1978). Moreover, chrysotile ingested long
term via the drinking water (0.5 g/L) in rats
suggests that absorption of nonmetabolizable
sugars from the GIT is adversely affected
(Delahunty & Hollander, 1987). However, in
Syrian golden hamsters given amosite or short-
or intermediate-range chrysotile in the diet
(at a concentration of 1% of pelleted diet)
for their lifetime, no increases in neoplasms
were seen for either ﬁber type (McConnell
et al., 1983). In addition, the complete set
of National Toxicology Program (NTP) feed
studies provided no convincing evidence of GI
neoplasms overall (NTP , 1985, 1988, 1990).
In Vitro Studies
Few in vitro studies were conducted using
cells derived from the GIT system. However, it
is known that asbestos ﬁbers penetrate epithe-
lial cells of both the pulmonary and GIT systems
(Mossman, 1983). In addition, the variable
effects of asbestos on GIT epithelium exposed
to asbestos are likely a result of differences in
surface charge, crystallization, and dimensional
characteristics (Mossman, 1983).
Summary
The GIT effects produced by asbestos
exposure appear to be minimal, but data are
inconclusive at best. The most likely result of
exposure to asbestos, either environmentally
or through occupational hazards, is develop-
ment of stomach cancer. Chrysotile appears to
pose a greater threat than crocidolite. However,
IARC recently concluded the evidence to sup-
port asbestos-induced stomach cancer to be
“limited” (Straif et al., 2009). There is a
great deal of inconsistency in the studies of
the GIT effects of asbestos, making it difﬁ-
cult to come to any strong conclusions (see
Table 3).
However, in summary the following were
concluded:
• The GIT effects of asbestos are rela-
tively infrequent as compared to the pul-
monary and peritoneal effects; however,
there remains the possibility for a link to
stomach cancer.
• The studies on asbestos in drinking water and
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TABLE 3. Publications on Asbestos-Induced Gastrointestinal Disease
Endpoint Fiber type (if known) Occupational exposure Ingested/water Animal studies
GI cancer (general) Chrysotile 6(–)a 1(–)c 1(+)d
2(+)b
Crocidolite 1(–)e
Unknown 5(+)f 3(–)h
2(–)g
Amosite or Tremolite 2(–)i
Colon/colorectal cancer Unknown 3(+)j 1(+)k
Chrysotile 3(+)l
Crocidolite 1(+)m
Stomach cancer Unknown 4(+)n 2(+)o
Crocidolite 3(+)p
1(–)q
Chrysotile 2(+)r
Note. The number indicates how many articles were found with a positive (+) or negative (–) association between asbestos and disease.
“Unknown” exposures indicate the data came from occupational exposure matrices, including textiles, insulation, or cement workers.
Sources: aBerry, 1983; Thomas, 1982; Pira, 2009; Albin, 1990; Gardner, 1986; Finkelstein, 1989. bFinkelstein, 1984; Weiss, 1977. cToft,
1983. dJacobs, 1978a. eReid, 2004. fKang, 1997; Lumley, 1976; Lacquet, 1980; Newhouse, 1985; Selikoff, 1974. gHodgson, 1986; Tsai,
1996. hBrowne, 2005; Harrington, 1978; Levy, 1976. iMcConnell, 1983a, 1983b. jGermani, 1999; Albin, 1990; Szeszenia-Dabrowska,
1998. kKjaerheim, 2005. lCorpet, 1993; Amacher, 1974; Donham, 1980. mCorpet, 1993. nLumley, 1976; Sun, 2008; Enterline, 1987;
Raffn, 1989. oKjaerheim, 2005; Andersen, 1993. pNewhouse, 1988; Armstrong, 1988; Botha, 1986. qde Klerk, 1989a. rKanarek, 1980;
Polissar, 1983.
The following are areas that need further
study:
• It would be helpful if studies evaluating
cohorts exposed through drinking water
examined the mineral content of the water.
• Additional animal studies evaluating the GIT
effects of orally administered asbestos with
different mineral content (i.e., Fe, nickel,
etc.).
• Additional animal studies examining the GIT
affects following inhalation exposure.
• Additional studies examining rate of ﬁber
passage versus retention in the GIT tract
following ingestion.
REPRODUCTIVE AND
DEVELOPEMENTAL EFFECTS
OF ASBESTOS
The reproductive effects of asbestos are
poorly understood but include ovarian cancer
and possibly an increase in the occurrence of
stillborn babies and infant mortality as well
as childhood mesothelioma. While there are
case studies describing intratesticular malig-
nant mesothelioma in relation to asbestos
(Attanoos & Gibbs, 2000), it is an extremely
rare and poorly characterized disease. In addi-
tion, there is limited epidemiological evidence
showing an increased odds ratio (OR) for can-
cer of the testes following asbestos exposure
(Polissar et al., 1982).
Adverse effects to the reproductive sys-
tem were ﬁrst considered following passive
observations of an elevated rate of ovar-
ian cancer in cohorts of asbestos exposure.
In fact, early reports linking asbestos with
ovarian cancer include a report of 9 out of
23 women with asbestosis dying of abdominal
neoplasms thought to be of ovarian origin (Keal,
1960). More recently, evidence using electron
microscopy (EM) showed that transplacental
transfer of asbestos ﬁbers occurs (Haque et al.,
1992). This led to studies on the effects of
prenatal exposure to asbestos.
Epidemiological Evidence
Epidemiological evidence supporting an
increased incidence of ovarian cancer due
to asbestos exposure has been a matter of
debate. There are a number of suggestive stud-
ies; however, most of these reports fail to134 M. BUNDERSON-SCHELVAN ET AL.
reach statistical signiﬁcance. In addition, the
potential for misdiagnosis of primary diffuse
malignant peritoneal mesothelioma in women
further complicates the issue (Kerrigan et al.,
2002), particularly in older studies that did not
use speciﬁc markers directed toward serous
ovarian carcinoma (Bollinger et al., 1989).
Nevertheless, IARC recently concluded that
the evidence to date is sufﬁcient to con-
sider asbestos an ovarian carcinogen (Straif
et al., 2009). Studies include a cohort of East
London factory workers from 1933–1980 who
reportedly elevated rates of ovarian cancer
(Newhouse et al., 1985 and a conﬁrma-
tion of excessive ovarian cancer in female
gas mask assemblers during World War II
(Wignall & Fox, 1982; Acheson et al., 1982).
Furthermore, in a study of Italian women com-
pensated for asbestosis, an increase in ovarian
cancer was reported (Germani et al., 1999)
and more recently in Italian cement workers
(Magnani et al., 2008). Other studies demon-
strated increased OR for ovarian cancer in
exposed women include a cohort of Australian
blue asbestos workers (Reid et al., 2009),
Italian textile workers (Pira et al., 2005), and
female Norwegian pulp workers (Langseth &
Kjaerheim, 2004). Again, while the ﬁndings in
the studies listed here did not always reach
signiﬁcance, taken together they provide note-
worthy evidence of a link between asbestos
exposure and ovarian cancer.
In addition to ovarian cancer, asbestos
may exert adverse effects on other aspects of
the reproductive system. Transplacental trans-
fer of asbestos was ﬁrst considered following
the observation that mesothelioma in chil-
dren has a shorter latency period than is
common in adults following asbestos expo-
sure (Wassermann et al., 1980). Transplacental
transfer is further supported by evidence that
when the exposure can be traced to early in
childhood, the latency period remained similar
to that seen in adults (21–25 yr) (Wassermann
et al., 1980) (for additional information see
Testa et al., this issue). Furthermore, this implies
the possibility that prenatal exposure may result
in highly malignant cases of mesothelioma in
children.
In addition to an increased risk of
childhood mesothelioma, there is some evi-
dence suggesting that transplacental transfer of
asbestos results in elevated frequency of infer-
tility, stillbirth, and infant mortality. Speciﬁcally,
a rise in the number of stillborn babies was
reported in women working in Russian asbestos
factories (Tsurikova et al., 1992). Haque et al.
(1992) used EM to examine the lungs, liver,
and placenta from ﬁve stillborn infants. An
asbestos ﬁber burden ranging from 71,000 to
357,000 ﬁbers/g wet weight was detected in
at least one organ of all ﬁve infants (Haque
et al., 1992). Haque et al. (1996) continued
by examining the organs from 40 stillborn
infants and comparing them to the placenta
from liveborn controls. Tissue digests were
characterized as to the type of asbestos using
EDXA-EM and selected-area diffraction analy-
sis. Small, thin, uncoated asbestos ﬁbers were
found in 15 of the 40 stillborn infants, while
no ﬁbers were found in the placental tissue
of any live-born controls (Haque et al., 1996).
Interestingly, in a larger third study by Haque
et al. (1998) using the same methods, low
numbers of asbestos ﬁbers were also found in
15% of the live-born placental controls. This
suggests that there is a threshold for prenatal
exposure that is lethal to the fetus, but again
raises the possibility that the surviving infants
have a higher risk for developing childhood
mesothelioma.
Type and Route of Exposure
In studies on Chinese hamster ovary cells,
UICC chrysotile ﬁber type B was shown to exert
a greater toxicity than either UICC crocido-
lite or amosite (Neugut et al., 1978), suggest-
ing that chrysotile is more likely to produce
adverse reproductive effects. However, there is
little work that has been done to support this
assumption.
There have been few studies exploring the
route of exposure for asbestos-induced ovarian
cancer, probably because most epidemiolog-
ical studies focus on occupationally exposed
men. However, using analytic EM, asbestos
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of women with known contact (Heller et al.,
1999). In a study of Norwegian pulp workers
who were diagnosed with ovarian cancer, ﬁbers
were found in the ovaries of two women with
possible secondary exposure from a spouse
also employed in the industry (Langseth et al.,
2007). In addition, a signiﬁcant asbestos bur-
den was found using analytic EM in the ovaries
of women with no documented exposure other
than being married to an asbestos worker
(Heller et al., 1996). It is known from early
studies that carbon particles injected into the
vaginal space of women while under anesthe-
sia were detected in the Fallopian tubes within
a few hours (Egli & Newton, 1961). Therefore,
likely routes of contact include traditionally
deﬁned occupational exposure (inhalation and
ingestion) as well as possible secondary expo-
sure during coitus.
Prenatal asbestos exposure might occur fol-
lowing any type of contact that would result
in systemic distribution of the ﬁbers and allow
for transplacental transfer to occur. This would
include occupational (inhalation), as well as
environmental exposures.
Animal Studies
There are few studies measuring the effects
of asbestos on reproduction in vivo. However,
ip injection of asbestos in guinea pigs and
rabbits resulted in changes in ovarian epithe-
lial cells similar to that seen in the early
stages of ovarian cancer (Graham & Graham,
1967). Furthermore, Schneider and Maurer
(1977) observed a decrease in postimplanta-
tion survival of embryos in pregnant CD-1
mice given chrysotile asbestos in their drinking
water.
It was also demonstrated through the use of
EDXA-EM analysis that asbestos is transferred to
the fetus through the placenta in pregnant mice
given an iv dose of asbestos (Haque & Vrazel,
1998), and transplacental transfer of chrysotile
asbestos was also found in rats (Vanchugova
et al., 2008). In addition, oral administration of
chrysotile asbestos to pregnant mice resulted in
ﬁbers detected in the lung and liver of pups by
EDXA-EM (Haque et al., 2001).
In Vitro Studies
Mechanisms of asbestos-induced ovarian
cancer and infertility are poorly understood.
However, a cell-mediated immunity towards
primary rat fetal cells from rats with Canadian
chrysotile B ﬁber-induced mesothelioma was
observed (Stevens et al., 1983), suggesting a
link between fetal death and the immune sys-
tem. In addition, a decrease in surface labeling
of glycolipids and glycoproteins in hamster
embryos treated with chrysotile asbestos was
noted (Saat et al., 1980), along with a rise in
micronucleated human amniotic cells (Dopp
et al., 1997). Furthermore, incubation of
rat embryo cells with crocidolite for 2–48h
resulted in an increase in DNA strand breakage
within 2–6 h (Libbus et al., 1989).
Summary
Overall, there has been little work on the
reproductive consequences of asbestos (see
Table 4). However, there is sufﬁcient evidence
to draw concern and warrant further investi-
gation. Particularly, more studies are required
to solidify the concerns regarding asbestos and
ovarian cancer. In addition, effects on fertility
and the developing fetus need to be closely
examined.
In summary, the following broad possi-
bilities regarding the reproductive effects of
asbestos were concluded:
• High levels of asbestos exposure has a high
probability of resulting in ovarian cancer.
• Women who have occupational exposure
and who also live with someone who works
with asbestos have the highest risk for ovarian
cancer.
• While there are case reports of asbestos-
related testicular mesothelioma, it is an
extremely rare disease.
• Evidence suggests transplacental transfer of
asbestos can occur.
• Transplacental transfer of asbestos may result
in an increase in stillborn infants.
• At low levels of prenatal asbestos exposure
there is the possibility of increased childhood
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TABLE 4. Publications on Asbestos-Induced Reproductive Disease/Disorders
Primary route Human Animal
Endpoint Fiber type of exposure studies studies In vitro
⇑Infant mortality/stillbirths Chrysotile Transplacental 4(+)a 1(+)b
Decreased fertility Chrysotile Ingested 1(+)c 3(+)d
Ovarian cancer Chrysotile and/or crocidolite Occupational 9(+)e 1(+)g
1(–)f
Intratesticular mesothelioma Unknown, case studies Occupational 1(+)h
Tumors of the testis Unknown Drinking water 1(+)i
Note. The number indicates how many articles were found with a positive (+) or negative (–) association between asbestos and disease.
“Unknown” exposures indicate the data came from occupational exposure matrices, including textiles, insulation, or cement workers.
Sources: aHaque, 1992; 1996; 1998; Tsurikova, 1992. bHaque, 2001. cSchneider, 1977. dSaat, 1980; Dopp, 1997; Stevens, 1983.
eGermani, 1999; Langseth, 2004; Magnani, 2008; Pira, 2005; Reid, 2009; Acheson, 1982; Newhouse, 1985; Wignall, 1982; Berry,
2000. fMillette, 1983. gGraham, 1967. hAttanoos, 2000. iPolissar, 1982.
The following are areas that need further
study:
• Animal studies examining the link between
asbestos and ovarian cancer are needed to
further clarify the strength of the association.
• Prenatal exposure and childhood mesothe-
lioma is little more than a hypothesis at this
point; therefore, epidemiological and ani-
mal studies would provide a large degree of
insight.
• Infertility due to asbestos exposure is a deﬁ-
nite possibility, and has been poorly studied
at this point.
• Increased stillborn and infant mortality due
to prenatal asbestos exposure should be fur-
ther examined.
MISCELLANEOUS EFFECTS
OF ASBESTOS
The possibility of other asbestos-induced
health effects does exist. These include brain-
related tumors, blood disorders due to the
mutagenicandhemolyticpropertiesofasbestos,
and peritoneal ﬁbrosis—although this has only
been documented in animals. In addition, the
cocarcinogenic potential of asbestos needs to
be considered as a possible health threat.
Epidemiology Studies
There is little evidence to link asbestos
exposure with a rise in brain-related tumors.
However, studies reporting a positive asso-
ciation include an increase in the number
of deaths due to brain tumors observed in
petrochemical workers exposed to asbestos in
the United States and Canada (Seidman et al.,
1982) and rock salt workers in Italy (Tarchi
et al., 1994). In addition, there are a num-
ber of cases of malignant brain tumor metas-
tases from pleural mesothelioma (Kawai et al.,
1997; Wronski & Burt, 1993; Falconieri et al.,
1991).
In addition to brain tumors, there is some
evidence linking blood-related disorders to
asbestos. Evidence includes an increase in the
number of double-stranded DNA breaks in
white blood cells from workers with an occu-
pational exposure to crocidolite (Marczynski
et al., 1994). Furthermore, when human
peripheral blood lymphocytes were incubated
with chrysotile, an inhibition of blastoid trans-
formation and beta-2 microglobulin produc-
tion was observed (Nakatani, 1983). Additional
reports have shown a rise in the concentration
of 8-hydroxy 2’-deoxyguanosine adducts in the
DNA from the blood of highly exposed workers
(Marczynski et al., 2000).
Animal Studies
Evidence of blood-related pathologies due
to asbestos exposure exist in animal studies,
although it is unknown whether the effect is
direct or a consequence of increased inﬂam-
mation. Nevertheless, chrysotile was found to
be highly hemolytic to rat erythrocytes (NadeauNONPULMONARY OUTCOMES OF ASBESTOS EXPOSURE 137
et al., 1987) as well as to red blood cells
in humans, rats, and sheep (Pele & Calvert,
1983). Oxidative stress was suggested to play
an important role in these pathologies using
common methods to measure markers of
reactive oxygen species. Speciﬁcally, analysis
of red blood cells from rats 30 d follow-
ing a single intratracheal exposure to either
chrysotile or crocidolite revealed an eleva-
tion in lipid peroxidation as measured by
thiobarbituric acid-reactive substances (TBARS)
activity, as well as decreased total glutathione
and ascorbic acid levels (Afaq et al., 1998).
In addition, increases in malondialdehyde,
an end-product of lipid peroxidation, were
measured in response to crocidolite treat-
ment in human peripheral blood-derived neu-
trophils, guinea pig peritoneal macrophages,
and guinea pig alveolar lung lavage cells (Yano,
1988).
A link between asbestos and peritoneal
ﬁbrosis is supported by studies utilizing mice
as models for ﬁbrogenesis. These reports
showed a rise in events leading to initiation
of a ﬁbrogenic response in the mouse peri-
toneum following delivery of chrysotile using
a sealed diffusion chamber (Bateman et al.,
1982) or injected directly into the peritoneal
cavity (Wirth, 1975). In addition, medium
from rat peritoneal macrophages incubated
with asbestos released ﬁbrogenic factors in rat
ﬁbroblasts (Aalto & Heppleston, 1984).
In Vitro Studies
In vitro systems were used to study the
cocarcinogenic effects of asbestos as well as
looking at potential mechanistic pathways. For
example, benzo[a]pyrene (BaP), a common
carcinogen resulting from incomplete combus-
tion of organic materials (including common
foods) (Le Marchand et al., 2002), was found
to increase mutagenicity when given concomi-
tantly with asbestos to rat liver epithelial cells
(Reiss et al., 1983). Perhaps the ﬁbers act as
cocarcinogens by allowing adsorbed contami-
nants access to the cell. This is supported by
evidence that chrysotile enhances the uptake
of BaP in rat liver microsomes (Lakowicz &
Bevan, 1980). In addition, chrysotile was found
to reduce the ability of the cells to metab-
olize BaP (Kandaswami & O’Brien, 1983).
Kandaswami et al. (1986) suggested that these
phenomena are due to chrysotile’s ability
to inhibit critical microsomal enzymes such
as aryl hydrocarbon hydroxylase, aminopy-
rine N-demethylase, and dimethylnitrosamine
demethylase. Furthermore, when crocidolite
treated with BaP was given to rats in the drink-
ing water, DNA strand breaks were potentiated
(Varga et al., 1999), and chrysotile adminis-
tered alone to rat liver epithelial cells is a
potent inducer of binucleation (Pelin et al.,
1995).
Mechanistic studies demonstrated an
increase in lipid peroxidation in rat liver
microsomes treated with either crocido-
lite or chrysotile (Fontecave et al., 1987;
Gulumian et al., 1983), suggesting that oxida-
tive stress may also play a role in the toxicity
of asbestos. This is further supported by the
ability of N-acetylcysteine to inhibit the gene
expression of proliferin in the pluripotent
C3H10T1/2 stem cell line following treatment
with amosite, crocidolite, or chrysotile (Parfett
et al., 1996). Moreover, phospholipase A(2)
and phosphokinase C inhibitors prevented
a chrysotile-induced increase in superoxide
formation in murine peritoneal macrophages
(Nakajima et al., 2000). When a noncellular
system was used to test the ability of asbestos
to generate the hydroxyl radical, crocidolite
proved to have the greatest potency, followed
by amosite and then chrysotile. This trend
correlated well with pleural inoculations in rats
(Maples & Johnson, 1992).
NON-PULMONARY ENDPOINTS OF
ASBESTOS EXPOSURE—HYPOTHESIS
FOR MECHANISM OF ACTION
In order for asbestos to produce non-
pulmonary pathologies, at least one of the
following must occur:
• Translocation of the ﬁbers to nonpulmonary
sites.138 M. BUNDERSON-SCHELVAN ET AL.
• Activation of systemic signaling (cytokines,
immune activities, etc) that impacts nonpul-
monary sites.
• Metastasis of primary lung or pleural tumors
to nonpulmonary sites.
Tissue Asbestos Burden and
Translocation
Researchregardingtheﬁbermovementand
tissue burden of asbestos has been an impor-
tant component to our current understanding
of the effects of asbestos (see Table 5). In the
lung it affects exposure assessment due to the
tendency of asbestos to bioaccumulate. In non-
pulmonary systems, the issue is signiﬁcant due
to the potential for translocation to other tis-
sues. The majority of reported cases of asbestos
exposure are occupational in nature. However,
other pathways include contaminated food and
water sources, as well as secondary exposures
due to contact with someone who has been
occupationally exposed.
Unfortunately, there are inherent difﬁ-
culties in the study of ﬁber distribution,
particularly regarding detection and quantiﬁ-
cation of the ﬁbers. Historically, detection
depended on light microscopy visualization of
asbestos bodies or ferruginous bodies. This
method has innate shortcomings due to dif-
ﬁculty in ﬁnding the appropriate orientation
of the sample. However, light microscopy is
reportedly dependable for detection of ﬁbers
larger than 0.3 μm in width. More accurate
detection of thinner ﬁbers requires electron
microscopy (Dodson et al., 2007). Most of the
more current literature used multiple detec-
tion techniques to maximize conﬁdence in
the data.
Tissue burden Occupational asbestos
exposure is primarily via the lungs with
a secondary exposure to the GIT through
inadvertent swallowing of the ﬁbers. There
is increasing evidence for systemic expo-
sure following inhalation of asbestos ﬁbers,
allowing for the possibility of asbestos contact
with distal tissues. For example, chrysotile
ﬁbers were detected by TEM in the urine
of workers in a factory producing roof tiles
(Finn & Hallenbeck, 1984), and by LM in the
TABLE 5. Publications on Asbestos Tissue Burden/Translocation
Tissue Disease outcome Fiber type Exposure Human Animal
Lymph nodes, lung
draining
Asbestosis or lung cancer Amphibole Chrysotile Occupational 3(+)a
Lymph nodes, thoracic Unknown Short, noncommercial
amphiboles
Nonoccupational
(environmnt)
1(+)b
Lymph nodes, thoracic Pleural meso Crocidolite Cigarette ﬁlters 1(+)c
Lymph nodes,
para-aortic/mesen
Asbestos-related lung
disease
Mixed amph/chrys Low-level occupational 1(+)d
Liver See note e Mixed Pulmonary or gavage 3(+)f 1(+)g
Spleen See note e Mixed Pulmonary or gavage 2(+)h 2(+)i
Colon Colon carcinoma Amosite and chrysotile Occupational 2(+)j
Kidney Lung cancer or meso Crocidolite Occupational or gavage 3(+)k 1(+)l
Ovary Risk for ovarian cancer? Crocidolite and
chrysotile
Household contact 3(+)m
Transplacental Stillborn “short, thin ﬁbers” Maternal (environmt) 3(+)n
Omentum, mesentery Risk of peritoneal
mesothelioma?
Amphiboles and
chrysotile
Various 3(+)o
Pancreas Asbestosis Mixed Occupational or gavage 1(+)p 1(+)q
Heart See note e Mixed Occupational or gavage 1(+)r 1(+)q
Note. The number indicates how many articles were found with a positive (+) or negative (–) association between asbestos and
outcomes. Sources: aDodson, 2007; 1990; Tossavainen, 1994. bDodson, 2000. cDodson, 2006. dUibu, 2009. eAlthough no dis-
ease outcome was noted, ﬁbers were detected in these studies. fWatanabe, 1994; Kobayashi, 1987; Huang, 1988. gWilliams, 2001.
hKobayashi, 1987; Watanabe, 1994. iKaczenski, 1984, Williams, 2001. jEhrlich, 1991; Huang, 1988. kWatanabe, 1994; Kobayashi,
1987; Tossavainen, 1994. lPatel-Mandlik, 1983. mHeller, 1996; 1999; Langseth, 2004. nHaque, 1996, 1992, 1998. oDodson, 2000;
2001; Heller, 1996. pHuang, 1988. qKaczenski, 1984. rKobayashi, 1987.NONPULMONARY OUTCOMES OF ASBESTOS EXPOSURE 139
extrapulmonary tissue from workers with occu-
pational exposure (Langer, 1974). Asbestos
burden evaluated in autopsied cases by EDXA-
TEM also showed that extrapulmonary ﬁbers
increase as pulmonary values rise while the
ﬁber type remains consistent (Huang et al.,
1988). Furthermore, a lung asbestos burden
of 0.45 million ﬁbers/g dry tissue or greater
as measured using EDXA-TEM has been useful
in predicting ﬁber burden in the abdominal
lymph nodes of individuals believed to have
died from asbestos-related disease (Uibu et al.,
2009).
Fiber Translocation Studies support wide-
spread distribution of asbestos, starting with
likely clearance from the lung (or peritoneum)
via macrophages to the draining lymph nodes
(Dodson et al., 1990, 1991, 2000, 2007) (for
additional information see Mossman et al., this
issue, and Aust et al., this issue.). In addi-
tion, evidence of lymphatic trafﬁcking of the
ﬁbers comes from studies showing the pres-
ence of ﬁbers in the spleen (Huang et al.,
1988; Kobayashi et al., 1987; Williams et al.,
2001), liver, and kidney (Huang et al., 1988;
Kobayashi et al., 1987; Williams et al., 2001;
Tossavainen et al., 1994). Due to the abil-
ity of asbestos to translocate from the lung
to the rest of the body via pulmonary lymph
and the blood stream, systemic exposure may
be highly inﬂuenced by ﬂuid dynamics of the
exposed individual (Miserocchi et al., 2008).
Further, it is likely that asbestos exposure results
in an impaired barrier function of the lung.
This is supported by a report that lung instil-
lation of polyethylene glycol (PEG) polymers in
rats along with crocidolite resulted in increased
urinary recovery of >854-kD PEGs (Folkesson
et al., 1993).
Animal Studies While most studies use
human autopsy samples from asbestosis or
asbestos-related cancer patients, a few studied
ﬁber distribution following exposure in ani-
mals. Chrysotile delivered through the food
supply results in ﬁbers being detected in
the kidneys (50 mg/kg dose, analyzed by
TEM) (Patel-Mandlik & Millette, 1983), lungs
(1.5–3.0 g/L dose, as indicated by the presence
of asbestos bodies) (Hasanoglu et al., 2008),
and bloodstream (Weinzweig & Richards,
1983) of rats and in the kidneys of baboons
(measured using TEM) (Patel-Mandlik et al.,
1979). In addition, ﬁbers were detected by
TEM in the stomach, heart, spleen, pancreas,
and blood of baboons gavaged cumulatively
with 800-mg doses of either chrysotile or cro-
cidolite ﬁbers (Kaczenski & Hallenbeck, 1984).
In rats, asbestos ﬁbers were found in the lymph
2–24 h following oral exposure with 50% of
the total load absorbed within 6 h (Masse
et al., 1980). In mice, studies on ﬁber con-
tent in tissue after ip instillation suggest the
ﬁbers penetrate rapidly (Winkler & Ruttner,
1982), whereas examination of the epithe-
lial lining of the gut following ingestion of
UICC chrysotile A or UICC crocidolite report-
edly showed no evidence of penetration when
examined by EM (Davis et al., 1974). Similarly,
the amphibole amosite (UICC) did not appear
to penetrate the GIT of rats when analyzed
by LM after a daily dose of 100 mg for 5 d
(Meek, 1983).
Summary
Fiber distribution after a variety of asbestos
exposures in both humans and animals pro-
vides evidence for widespread migration of
the ﬁbers to various organs. These data sup-
port the hypothesis that nonpulmonary effects
of asbestos might be due to the presence
of the ﬁbers in those sites. Nevertheless,
the literature does not rule out the possibil-
ity of a systemic effect that might enhance
carcinogenesis and ﬁbrosis in organs other
than those directly impacted by asbestos
exposure. The second and third hypotheses
that asbestos may enhance extrapulmonary
cancers as well as metastasis from primary
pulmonary tumors merit consideration, but
require further study. Large-scale prospective
studies of different asbestos exposures are
needed to more clearly understand the tem-
poral and mechanistic relationships of can-
cer in nonpulmonary sites following asbestos
exposure.140 M. BUNDERSON-SCHELVAN ET AL.
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